Malignant melanoma of the genitourinary tract.
D000310:Adrenal Gland Neoplasms / Q000453:epidemiology; D000328:Adult; D000368:Aged; D001500:BCG Vaccine / Q000627:therapeutic use; D002330:Carmustine / Q000627:therapeutic use; D003131:Combined Modality Therapy; D003606:Dacarbazine / Q000627:therapeutic use; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000453:epidemiology / Q000628:therapy; D016030:Kidney Transplantation; D008297:Male; D008545:Melanoma / Q000453:epidemiology* / Q000628:therapy; D008875:Middle Aged; D010412:Penile Neoplasms / Q000453:epidemiology / Q000628:therapy; D011471:Prostatic Neoplasms / Q000453:epidemiology; D011879:Radiotherapy Dosage; D013736:Testicular Neoplasms / Q000453:epidemiology; D014516:Ureteral Neoplasms / Q000453:epidemiology; D014523:Urethral Neoplasms / Q000453:epidemiology / Q000628:therapy; D001749:Urinary Bladder Neoplasms / Q000453:epidemiology / Q000628:therapy; D014565:Urogenital Neoplasms / Q000453:epidemiology* / Q000628:therapy
D001500:BCG Vaccine; D003606:Dacarbazine; D002330:Carmustine